Document is current
Any future updates will be listed below
-
Authors
Lithovius, Raija https://orcid.org/0000-0001-7313-4710
Mutter, Stefan
Parente, Erika B.
Harjutsalo, Valma
Groop, Per-Henrik
Thorn, Lena M.
Sandholm, Niina
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 15 July 2025
Accepted: 27 October 2025
First Online: 18 November 2025
Declerations
:
: The study protocol was approved by the Ethics Committee of the Helsinki and Uusimaa Hospital District, and the study was carried out in accordance with the Declaration of Helsinki. Written informed consent was obtained from each participant.
: SM received lecture honorarium from Encore Medial Education, PHG has received lecture honoraria from Astellas, Astra Zeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Eli Lilly, EloWater, Genzyme, Medscape, MSD, Mundipharma, Novartis, Novo Nordisk, PeerVoice, Sanofi and Sciarc. PHG is an advisory board member for AbbVie, Astellas, Astra Zeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Medscape, MSD, Mundipharma, Nestlé, Novartis, Novo Nordisk, and Sanofi. PHG has received investigator-initiated grants from Eli Lilly and Roche. EBP reports received lecture honorariums from Astra Zeneca, Sanofi during the last three years and has been an employee of Boehringer Ingelheim since February 2024. No other potential conflicts of interest relevant to this article were reported. The funding sources were not involved in the design or conduct of the study. All other authors declare that there is no duality of interest associated with this manuscript.
